|
|
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
|
5R44CA123994-06
|
$980,392
|
$323,529
|
GILLESPIE, JOHN
|
20/20 GENESYSTEMS, INC.
|
|
|
Novel agent to restore sensitivity to anti-estrogen therapy
|
N43CO120060-000
|
$199,380
|
$199,380
|
SERRERO, PH.D., GINETTE
|
A&G PHARMACEUTICAL, INC
|
|
|
Breast Cancer Oxaliplatin Microdosing Trial
|
N43CO120084-000
|
$199,969
|
$199,969
|
HENDERSON, PAUL
|
ACCELERATED MEDICAL DIAGNOSTICS
|
|
|
Ultrasound Ablation on Bone Cancer Under CT Fluoroscopy
|
5R44CA112852-05
|
$941,541
|
$94,154
|
Burdette, Everette
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
|
Automated Systems for Detection and Molecular Characterization of Circulating Tum
|
5R44CA122444-06
|
$979,021
|
$979,021
|
LUO, YULING
|
ADVANCED CELL DIAGNOSTICS, INC.
|
|
|
The 3D whole Body Distribution of NIR transferrin using FRET tomography imaging
|
5R21CA161782-02
|
$199,576
|
$199,576
|
BARROSO, MARGARIDA
|
ALBANY MEDICAL COLLEGE
|
|
|
Regulation of Fibronectin Matrix Assembly by uPAR
|
5R01CA058626-19
|
$272,648
|
$136,324
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
|
Concerted role for integrin alpha3beta1 and TGFb signaling in cancer progression
|
5F32CA153976-02
|
$53,942
|
$53,942
|
Subbaram, Sita
|
ALBANY MEDICAL COLLEGE
|
|
|
MOTILITY AND INVASION
|
5P01CA100324-10
|
$2,016,840
|
$2,016,840
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Signal Transduction & Actin During Amoeboid Chemotaxis
|
5R01CA150344-24
|
$353,827
|
$353,827
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Tumor microenvironments determing migration, dissemination and dormancy
|
5U54CA163131-02
|
$784,552
|
$517,804
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$1,014,503
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$67,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$67,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$20,250
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
EMT, Extravasation and metastasis by N-Cadherin signaling
|
5R01CA135061-04
|
$334,117
|
$334,117
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
R-Cadherin in Breast Cancer Suppression
|
5R01CA136854-04
|
$334,117
|
$334,117
|
HAZAN, RACHEL
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Novel approach to study intravasation in primary human breast cancer cells(PQ24)
|
1R01CA170507-01
|
$369,043
|
$369,043
|
oktay, maja
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Macrophages and Tumor Angiogenesis
|
5R01CA131270-05
|
$318,015
|
$318,015
|
POLLARD, JEFFREY
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Identifying the Mechanisms Governing Mena-Induced Tumor Cell Dissemination
|
5F32CA159663-02
|
$52,190
|
$52,190
|
Roh, Minna
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
microRNA expression profiling of benign breast tissue and breast cancer risk
|
5R01CA142942-03
|
$738,155
|
$738,155
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-38
|
$101,749
|
$2,035
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Influence of Fasting Status and Specimen Processing Time on Adipokine Levels
|
5R03CA143956-02
|
$57,016
|
$57,016
|
Strickler, Howard
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
In Vivo Multiphoton Based Imaging of Complex Cancer Cell Behavior
|
5R01CA164468-02
|
$765,967
|
$382,984
|
Verkhusha, Vladislav
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
Community Clinical Oncology Program
|
5U10CA037422-25
|
$4,499,349
|
$809,883
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-36S1
|
$172,284
|
$13,783
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-36
|
$12,915,055
|
$1,033,204
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Molecular Recognition by Bleomycin
|
5R01CA140471-03
|
$306,945
|
$306,945
|
Hecht, Sidney
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Biomarker Detection Using NAPPA Tumor Antigen Arrays
|
3U01CA117374-08S1
|
$58,809
|
$58,809
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Biomarker Detection Using NAPPA Tumor Antigen Arrays
|
5U01CA117374-08
|
$730,476
|
$730,476
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Geospatial Factors and Impacts II
|
2R01CA126858-05
|
$403,837
|
$201,919
|
MOBLEY, LEE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$145,850
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
Progesterone Receptor Binding to Specific DNA Sequences
|
5R01CA046938-24
|
$242,682
|
$121,341
|
EDWARDS, DEAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The Study of the Circadian Rhythm in p53 Signaling
|
5R01CA137019-03
|
$291,218
|
$145,609
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
3R01CA072038-15S1
|
$49,685
|
$49,685
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A Hypersensitive ER alpha Mutant in Breast Cancer Hormone Resistance
|
5R01CA072038-15
|
$291,192
|
$291,192
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Translational Breast Cancer Research Training Program
|
5T32CA090221-10
|
$183,921
|
$183,921
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The Role of Long Non-coding RNAs in EMT and Cancer Stem Cells
|
1K99CA166815-01A1
|
$165,956
|
$165,956
|
Herschkowitz, Jason
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Mechanisms of the Adenovirus E4-ORF1 Oncoprotein
|
5R01CA058541-18
|
$307,553
|
$307,553
|
Javier, Ronald
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Molecularly guided multimodal theranostics for breast cancer
|
5R01CA151962-03
|
$334,627
|
$334,627
|
JOSHI, AMIT
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Prevalence of CD24 epigenetic silencing in breast tumors and ERalpha status
|
5R03CA150027-02
|
$78,250
|
$78,250
|
Kaipparettu, Benny
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
C/EBPb Modulates Macrophages and Tumor-Initiating Cells During Preneoplastic Prog
|
5K99CA154605-02
|
$158,552
|
$158,552
|
LaMarca, Heather
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Regulation of Mammary Stem Cells
|
3R01CA127857-05S1
|
$48,119
|
$48,119
|
LEWIS, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Regulation of Mammary Stem Cells
|
5R01CA127857-05
|
$308,958
|
$308,958
|
LEWIS, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Oncogene susceptibility: physiological state & breast cell differentiation
|
5R01CA124820-03
|
$308,957
|
$308,957
|
LI, YI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Characterization and targeting BRIT1 deficiency in breast cancer
|
5R01CA155151-02
|
$324,738
|
$324,738
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Heparanase Mechanisms in Brain-metastatic Breast Cancer
|
5R01CA160335-02
|
$297,350
|
$297,350
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$8,287
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$15,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$586,952
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Total relevant funding to Breast for this search: $602,728,719
|
